HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALEBUND-B

31.020

-0.240-0.77%

Volume:23.20K

Turnover:722.01K

Market Cap:10.79B

PE:-10.10

High:31.960

Open:30.640

Low:30.600

Close:31.260

52wk High:46.820

52wk Low:22.720

Shares:348.00M

HK Float Shares:236.00M

Volume Ratio:0.33

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.071

ROE:--

ROA:-33.01%

PB:6.57

PE(LYR):-10.10

PS:75.51

Loading ...

Overview Company News Filings

Movement Alert｜Alebund Pharmaceuticals-B Falls 21.6% in Regular Trading, Post-IPO Correction Approaches Offer Price

Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI

Crealights, Baige, Alebund Pharmaceuticals Jump in Hong Kong Debut

ALEBUND-B Makes Hong Kong Stock Exchange Debut: Pioneering a New Growth Model for Biotech in Vertical Chronic Disease Arena

Alebund Pharmaceuticals Jumps 86% in Hong Kong Trading Debut

MT Newswires Live

Stock Track | Alebund Pharmaceuticals Soars 84.16% in Intraday Trading on Strong Hong Kong IPO Debut

Movement Alert｜Alebund Pharmaceuticals-B Surges 80.53% in Regular Trading on IPO Debut with Nearly 964x Oversubscription

Alebund Pharmaceuticals Nets HK$1.2 Billion in Hong Kong IPO

MT Newswires Live

Alebund Pharmaceuticals (jiangsu) - Sets Final Offer Price at Hk$22.6 Per Offer Share

THOMSON REUTERS

ALEBUND-B Soars 94% in Pre-Market Trading, Set to List Next Monday

HK Grey Market | BAIGE DIGITAL Soars 341%; CREALIGHTS Jumps 93%; ALEBUND-B Jumps 77%

Tiger Newspress

Alebund Pharmaceuticals Releases Detailed Charter for Newly Formed Strategy Committee

Bulletin Express

Alebund Pharma Announces Current Board Line-up and Committee Leadership Structure

Bulletin Express

ALEBUND-B's IPO Attracts Unprecedented Lineup of 11 Top-Tier Cornerstone Investors in Hong Kong's 18A Market

Alebund Pharmaceuticals Launches HK$1.3 Billion Hong Kong IPO

MT Newswires Live

Alebund Pharmaceuticals：发行价每股22.60港元，拟募资约11.808亿港元完成全球发售

Bulletin Express

BRIEF-Alebund Pharmaceuticals (Jiangsu) Announces Offer Price Under Global Offering Of HK$22.60 Per Offer Share

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/09637/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","market":"HK","secType":"STK","nameCN":"ALEBUND-B","latestPrice":31.02,"timestamp":1788142909099,"preClose":31.26,"halted":0,"volume":23200,"delay":0,"changeRate":-0.007677543186180485,"floatShares":236000000,"shares":348000000,"eps":-3.071284,"marketStatus":"Trading","change":-0.24,"latestTime":"08-31 10:22:50","open":30.64,"high":31.96,"low":30.6,"amount":722012,"amplitude":0.043506,"askPrice":31.48,"askSize":400,"bidPrice":30.98,"bidSize":900,"shortable":0,"etf":0,"ttmEps":-2.326,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788148800000},"marketStatusCode":2,"adr":0,"listingDate":1782662400000,"exchange":"SEHK","adjPreClose":31.26,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.333241,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","floatShares":236000000,"roa":"-33.01%","roe":"--","lyrEps":-3.071284,"volumeRatio":0.333241,"shares":348000000,"dividePrice":0,"high":31.96,"amplitude":0.043506,"preClose":31.26,"low":30.6,"week52Low":22.72,"pbRate":"6.57","psRate":"75.51","week52High":46.82,"institutionHeld":0,"latestPrice":31.02,"committee":0.384615,"eps":-3.071284,"divideRate":0,"volume":23200,"delay":0,"ttmEps":-2.326,"open":30.64,"prevYearClose":22.6,"prevWeekClose":31.26,"prevMonthClose":27.24,"prevQuarterClose":45.92,"fiveDayClose":32.46,"twentyDayClose":29.48,"sixtyDayClose":22.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09637\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"09637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09637\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":3,"updateTime":1787846400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09637","date":"2026-08-28","current":-13.439381,"percent":0.465116,"low":-18.066068,"twenty":-13.077865,"median":-11.990608,"eighty":-10.959851,"high":-8.87585,"avg":-12.238532,"sd":1.702985,"marketCap":10623780741},"quantilePoints":[{"date":"2026-06-26","current":-8.87585,"twenty":-8.87585,"median":-8.87585,"eighty":-8.87585,"marketCap":7680660420},{"date":"2026-07-03","current":-11.883178,"twenty":-18.03155,"median":-11.883178,"eighty":-9.78101,"marketCap":10290725554},{"date":"2026-07-10","current":-12.164969,"twenty":-13.966639,"median":-11.847257,"eighty":-11.12129,"marketCap":10521825071},{"date":"2026-07-17","current":-10.947234,"twenty":-12.322489,"median":-11.455859,"eighty":-10.783874,"marketCap":9502268378},{"date":"2026-07-24","current":-11.320561,"twenty":-11.939536,"median":-11.377389,"eighty":-10.939493,"marketCap":9828526520},{"date":"2026-07-31","current":-10.642718,"twenty":-11.840073,"median":-11.194259,"eighty":-10.78337,"marketCap":9257574772},{"date":"2026-08-07","current":-12.743391,"twenty":-12.396338,"median":-11.399787,"eighty":-10.889159,"marketCap":11106370909},{"date":"2026-08-14","current":-13.03884,"twenty":-12.987078,"median":-11.462395,"eighty":-10.903987,"marketCap":11378252693},{"date":"2026-08-21","current":-12.870195,"twenty":-13.077865,"median":-11.725167,"eighty":-10.931752,"marketCap":11255905890},{"date":"2026-08-28","current":-12.144658,"twenty":-13.077865,"median":-11.990608,"eighty":-10.959851,"marketCap":10623780741}],"updateTime":1788107398471},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09637\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1189695991","title":"Movement Alert｜Alebund Pharmaceuticals-B Falls 21.6% in Regular Trading, Post-IPO Correction Approaches Offer Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1189695991","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189695991?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:48","pubTimestamp":1782956929,"startTime":"0","endTime":"0","summary":"On July 2, Alebund Pharmaceuticals-B declined 21.6% in regular trading, trading at HK$24.0/share, with turnover of HK$28.99 million.The stock listed on the Hong Kong Exchange on June 29 at an offer...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327725","title":"Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647327725?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:33","pubTimestamp":1782725580,"startTime":"0","endTime":"0","summary":"Chinese biopharma stocks rallied on Monday, as investors moved away from artificial-intelligence stocks amid concerns over overstretched valuations.Shares of BeOne Medicines led gains among biopharma ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","ISBC","603259","01093","09637","BK4137","IE00BZ08YS42.EUR","LABU","LU2039709279.SGD","LU1303224171.USD","ARTY","LU1807302812.USD","01801","01877","CHAT","LU1226287529.USD","ONC","IE00BPRC5H50.USD","BK1161","XBI","LU1008478684.HKD","BK1583","AIPO","BK1191","LU1255011170.USD","LU0405327494.USD","XLV","BK4585","BK1189","LU1993786604.SGD","BK0196","BK1502","HCSG","LU0315179316.USD","LU2328871848.SGD","LU1251922891.USD","00241","AGIX","02315","BK0028","86618","600276","688180","BK0012","LU1808992512.USD","LU0140636845.USD","BK0239","BK0216","LU0456827905.SGD","06618"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647932823","title":"Crealights, Baige, Alebund Pharmaceuticals Jump in Hong Kong Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2647932823","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647932823?lang=en_us&edition=fundamental","pubTime":"2026-06-29 13:03","pubTimestamp":1782709403,"startTime":"0","endTime":"0","summary":"BUZZ-Crealights, Baige, Alebund Pharmaceuticals jump in Hong Kong debut** Shares of Crealights Technology1191.HKsurge 45.5% from the offer price to HK$165.9 by lunchbreak at its Hong Kong debut, outpa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL1N43103F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01191","BK1147","09637","BK1537","02672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126070700","title":"ALEBUND-B Makes Hong Kong Stock Exchange Debut: Pioneering a New Growth Model for Biotech in Vertical Chronic Disease Arena","url":"https://stock-news.laohu8.com/highlight/detail?id=1126070700","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126070700?lang=en_us&edition=fundamental","pubTime":"2026-06-29 11:19","pubTimestamp":1782703196,"startTime":"0","endTime":"0","summary":"ALEBUND-B (HKEX: 09637) commenced trading on the main board of the Hong Kong Stock Exchange today, marking its debut as the first purely nephrology-focused 18A biotech company in the Hong Kong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4581","BK1515","09637","BK4585","HEXmain","09939","BK4588","BK1161","XBI","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647434424","title":"Alebund Pharmaceuticals Jumps 86% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2647434424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647434424?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:40","pubTimestamp":1782697218,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu)'s (HKG:9637) shares opened 86% above the offer price in a strong Hong Kong debut on Monday morning.The biopharmaceutical company opened at HK$42.00 per share, well above the offer price of HK$22.60.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186783542","title":"Stock Track | Alebund Pharmaceuticals Soars 84.16% in Intraday Trading on Strong Hong Kong IPO Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1186783542","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186783542?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:35","pubTimestamp":1782696934,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) shares soared 84.16% in intraday trading on Monday following its highly anticipated debut on the Hong Kong Stock Exchange.The biopharmaceutical company's stock opened at HK$42 per...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105208109","title":"Movement Alert｜Alebund Pharmaceuticals-B Surges 80.53% in Regular Trading on IPO Debut with Nearly 964x Oversubscription","url":"https://stock-news.laohu8.com/highlight/detail?id=1105208109","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105208109?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:34","pubTimestamp":1782696895,"startTime":"0","endTime":"0","summary":"On June 29, Alebund Pharmaceuticals-B (09637.HK) surged 80.53% in regular trading on its first day of listing, trading at HKD 41.98 per share with turnover of HKD 288 million. The stock was priced at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647344920","title":"Alebund Pharmaceuticals Nets HK$1.2 Billion in Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2647344920","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647344920?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:28","pubTimestamp":1782696486,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) (HKG:9637) raised HK$1.18 billion in net proceeds from its initial public offering in Hong Kong, according to a Friday after-market filing on the Hong Kong Exchange.T","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPOS","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646284365","title":"Alebund Pharmaceuticals (jiangsu) - Sets Final Offer Price at Hk$22.6 Per Offer Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2646284365","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646284365?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:45","pubTimestamp":1782485148,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nFWN42Y0HX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151324552","title":"ALEBUND-B Soars 94% in Pre-Market Trading, Set to List Next Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151324552","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151324552?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:30","pubTimestamp":1782477025,"startTime":"0","endTime":"0","summary":"In today's pre-market trading session, ALEBUND-B (09637), often referred to as the first kidney disease innovation drug stock on the Hong Kong market, closed at HK$43.88. This represents a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1161","09637","159938","BK1515","HEXmain","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150903291","title":"HK Grey Market | BAIGE DIGITAL Soars 341%; CREALIGHTS Jumps 93%; ALEBUND-B Jumps 77%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150903291","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150903291?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:57","pubTimestamp":1782460634,"startTime":"0","endTime":"0","summary":"$ALEBUND-B(09637)$ jumped 77% in Hong Kong’s grey market trading.ALEBUND-B is an innovative biopharmaceutical company dedicated to the field of kidney disease. Backed by an all-star lineup of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01191","09637","02672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153291767","title":"Alebund Pharmaceuticals Releases Detailed Charter for Newly Formed Strategy Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1153291767","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153291767?lang=en_us&edition=fundamental","pubTime":"2026-06-26 06:46","pubTimestamp":1782427575,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) Limited has published the Terms of Reference governing its newly established Strategy Committee, a body designed to support the Board of Directors in shaping...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130278563","title":"Alebund Pharma Announces Current Board Line-up and Committee Leadership Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=1130278563","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130278563?lang=en_us&edition=fundamental","pubTime":"2026-06-26 06:46","pubTimestamp":1782427570,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) Limited released an update on 26 June 2026 confirming the composition of its Board of Directors and the leadership of its four specialised committees. The Board...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146842484","title":"ALEBUND-B's IPO Attracts Unprecedented Lineup of 11 Top-Tier Cornerstone Investors in Hong Kong's 18A Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1146842484","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146842484?lang=en_us&edition=fundamental","pubTime":"2026-06-18 10:20","pubTimestamp":1781749212,"startTime":"0","endTime":"0","summary":"The Hong Kong 18A market has navigated eight years of evolution, moving decisively beyond an era of \"story-driven\" speculative growth. Following multiple rounds of valuation resets and liquidity...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1515","BK1574","09939","BK1161","159938","BK4585","BK4588","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644733817","title":"Alebund Pharmaceuticals Launches HK$1.3 Billion Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2644733817","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644733817?lang=en_us&edition=fundamental","pubTime":"2026-06-18 08:59","pubTimestamp":1781744343,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (HKG:9637) launched its Hong Kong initial public offering on Thursday, seeking to raise about HK$1.28 billion.The China-based biopharmaceutical company is offering 56.8 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09637","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173886818","title":"Alebund Pharmaceuticals：发行价每股22.60港元，拟募资约11.808亿港元完成全球发售","url":"https://stock-news.laohu8.com/highlight/detail?id=1173886818","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173886818?lang=en_us&edition=fundamental","pubTime":"2026-06-18 06:30","pubTimestamp":1781735424,"startTime":"0","endTime":"0","summary":"－－公司概况－－   Alebund Pharmaceuticals (Jiangsu)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alebund Pharmaceuticals：发行价每股22.60港元，拟募资约11.808亿港元完成全球发售","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644935775","title":"BRIEF-Alebund Pharmaceuticals (Jiangsu) Announces Offer Price Under Global Offering Of HK$22.60 Per Offer Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2644935775","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644935775?lang=en_us&edition=fundamental","pubTime":"2026-06-18 06:07","pubTimestamp":1781734028,"startTime":"0","endTime":"0","summary":"BRIEF-Alebund Pharmaceuticals  Announces Offer Price Under Global Offering Of HK$22.60 Per Offer ShareJune 18  - Alebund Pharmaceuticals : OFFER PRICE UNDER GLOBAL OFFERING HK$22.60 PER OFFER SHARENUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 56.8 MILLION H SHARESNUMBER OF INTERNATIONAL OFFER SHARES UNDER GLOBAL OFFERING 51,079,800 H SHARES ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42P0HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}]}}